Abdul, Mashrin .

HRN: 23-34-38  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2025
CEFUROXIME 750MG (VIAL)
05/22/2025
05/29/2025
IV
340mg
Q8
PCAP
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaBloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: